Table 2.
The association between risk factors at diagnosis and the odds of being prescribed budesonide in the first year after diagnosis.
| Budesonide in the first year after diagnosis | Adjusted odds ratio (95% confidence interval) | ||
|---|---|---|---|
| Yes (n = 110) | No (n = 73) | ||
| Age at diagnosis, years (SD) | 62.3 (13.7) | 62.5 | 1.00 (0.97–1.03) |
| Female gender, % | 78 | 81 | 0.85 (0.40–1.82) |
| Body mass index >30 kg/m2, % | 16 | 14 | 1.43 (0.59–3.47) |
| Smoker at diagnosis, % | 16 | 12 | 1.34 (0.55–3.27) |
| ASA a , % | 13 | 18 | 0.76 (0.28–2.08) |
| ASA b , % | 17 | 27 | 0.49 (0.21–1.17) |
| NSAIDs a , % | 14 | 8 | 2.06 (0.68–6.21) |
| NSAIDs b , % | 44 | 48 | 0.80 (0.42–1.51) |
| PPIs a , % | 24 | 20 | 1.10 (0.52–2.33) |
| PPIs b , % | 39 | 36 | 1.43 (0.73–2.80) |
| SSRIs a , % | 19 | 19 | 0.90 (0.40–2.01) |
| SSRIs b , % | 24 | 22 | 1.07 (0.50–2.26) |
| Statins a , % | 19 | 25 | 0.75 (0.31–1.80) |
| Statins b , % | 24 | 30 | 0.90 (0.40–2.06) |
a
Prescribed within 3 months before diagnosis.
b
Prescribed within 3 years before diagnosis.
ASA, acetylsalicylic acid; NSAID, non-steroidal anti-inflammatory drug; PPI, proton pump inhibitor; SD, standard deviation; SSRI, serotonin reuptake inhibitor.